CAPTRUST Financial Advisors’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$288K	Sell	4,364 -285	-6%	-$18.1K	﹤0.01%	2420
2025 Q4	$295K	Buy	+4,649	New	+$289K	﹤0.01%	2266
2024 Q1	–	Sell	-12,258	Closed	-$1.02M	–	2284
2023 Q4	$1.02M	Sell	12,258 -2,948	-19%	-$107K	﹤0.01%	1254
2023 Q3	$448K	Buy	15,206 +5,035	+50%	+$168K	﹤0.01%	1711
2023 Q2	$332K	Sell	10,171 -18	-0.2%	-$666	﹤0.01%	1897
2023 Q1	$359K	Sell	10,189 -687	-6%	-$28K	﹤0.01%	1611
2022 Q4	$498K	Buy	10,876 +6,699	+160%	+$288K	﹤0.01%	1331
2022 Q3	$202K	Buy	4,177 +304	+8%	+$14.6K	﹤0.01%	1816
2022 Q2	$152K	Sell	3,873 -37	-0.9%	-$1.49K	﹤0.01%	1894
2022 Q1	$144K	Buy	3,910 +1,735	+80%	+$61.6K	﹤0.01%	1973
2021 Q4	$99K	Buy	2,175 +18	+0.8%	+$695	﹤0.01%	2174
2021 Q3	$77K	Buy	2,157 +43	+2%	+$1.27K	﹤0.01%	2279
2021 Q2	$42K	Sell	2,114 -17	-0.8%	-$399	﹤0.01%	2623
2021 Q1	$50K	Buy	2,131 +1,991	+1,422%	+$42.5K	﹤0.01%	2425
2020 Q4	$3K	Sell	140 -260	-65%	-$4.75K	﹤0.01%	2986
2020 Q3	$9K	Buy	+400	New	+$9.36K	﹤0.01%	2319